Roseanne Meyer, B.S. Biochemistry (Cedar Crest College, PA)
M.S. candidate, URI
(Project 4) Member of King lab, September 2004 – current
Roseanne Meyer earned a B.S. degree in Biochemistry with concentration in Forensic Science from Cedar Crest College in Allentown, PA. She joined my lab in September 2004 is currently working on the human mammary epithelial cell portion of project 4.
Current student at URI, Biological Sciences and Chemistry
Nick joined my lab in September 2005 and is starting to work with the molecular modeling program Insight II.
Anasuya Ghosh, B.Pharm. (University of Bombay, Bombay, INDIA)
M.S. completed Dec 2001, URI
(Project 1) Member of King lab September 1999-September 2001
Anasuya earned her bachelors of pharmacy and worked for one year in Formulation Development for the division of Novartis Pharmaceuticals in India. She came to URI in Fall 1999, recruited by Dr. King. Anasuya defended her thesis in September 2001 and immediately began work for Novartis Pharmaceuticals in East Hanover NJ. Her thesis was entitled “Inhibition of human phenol sulfotransferase (SULT1A1).” She presented a portion of the project at an international meeting, the 10th North American ISSX Meeting, October 2000, Indianapolis, IN. Anasuya is currently employed by Novartis Pharmaceuticals and is a doctoral candidate in Pharmaceutical Sciences at Rutgers University.
Gautam Jha, M.B.B.S. Medicine (Terna Medical College & Hospital, Bombay, INDIA)
M.S. completed May 2002, URI
(Project 3) Member of King lab February 2000-January 2002
After earning his Bachelors of Medicine and completing internship and residency, Gautam came to URI in Fall 1999. He started in Dr. King’s lab in February 2000 and defended his thesis in January 2002. He worked for three months before his defense for a contract research laboratory in Boston. His thesis project was entitled “In vivo metabolism of 2-amino-alpha-carboline.” He presented a portion of the project at an international meeting, the 8th International Conference on Carcinogenic and Mutagenic N-Substituted Aryl Compounds, November 2001, Washington DC. Gautam worked for Millennium Pharmaceuticals for three years and is currently near the completion of US Medical Residency in New York City.
Erden Banoglu, Ph.D. Medicinal and Natural Products Chemistry (University of Iowa, IA)
Assistant Professor, Gazi University, Ankara, TURKEY
Visiting Scientist, August – October 2000
Dr. Banoglu came to Dr. King’s laboratory for three months to work on a collaborative project of his interest: Biotransformation of indole to indoxyl sulfate. He returned to Gazi University where he has been recently promoted to Associate Professor.
Dr. Zhixin Yuan, Ph.D. (University of London, UK)
Postdoctoral Research Associate 2002-2003
(Project 3) September 2002-December 2003
Dr. Yuan earned her Ph.D. degree in Biochemistry from the University of London, UK, in 1996. Her thesis topic was the metabolism and pharmacokinetics of tamoxifen. She then came to the US and worked as postdoctoral fellow in the Environmental Toxicology and Chemistry Laboratory of the Research Foundation of SUNY Buffalo. Her projects included metabolism and toxicology of various polycyclic aromatic hydrocarbons. She joined my lab in September 2002 well-prepared for the research I was conducting, and she completed the cellular metabolism of AaC with complete structure determination of the metabolites. Dr. Yuan moved from my lab back to Washington DC to be closer to her family. She worked at NIH for one year and then earned a permanent position at a contract laboratory.
Jinfang Wu, B.S. Medicine (Nanjing University, China)
M.S. completed May 2005, URI
(Project 1 and 4) Member of King lab September 2002 – December 2004
Jinfang Wu earned a Bachelor of Medicine degree in 1998 from Nanjing University. After a one year internship at Nanjing Drum Tower Hospital she returned to Nanjing University as a doctoral student in the School of Medicine. In September 2002 she joined my lab at URI as a student in Pharmacology and Toxicology. Jinfang’s thesis was entitled “Effect of Human Estrogen Sulfotransferase Inhibitors on Breast Cancer Cells” (defended May 2005).
Office Phone: (401) 874-7061
Lab Phone: (401) 874-9039
Fax: (401) 874-5787
E mail: email@example.com